Invasive fungal diseases (IFDs) represent an important cause of treatment failure in adults
with acute leukemia. Because of leukemia's heterogeneity, the risk for IFDs is highly …

Invasive fungal infection (IFI) is among the leading causes for morbidity, mortality, and
economic burden for patients with acute leukemia. In the past few decades, the incidence of …

Invasive fungal disease (IFD) is a significant cause of morbidity and mortality in patients
undergoing treatment for acute leukemia (AL). Antifungal prophylactic strategies are …

This is a retrospective, single-center study of adult patients with newly diagnosed acute
myelogenous leukemia (AML), who received intensive induction timed sequential …

Patients with acute leukemia who initially survive invasive fungal disease must receive
chemotherapy or go on to transplant. Many centers change subsequent chemotherapy to …

Objectives We sought to determine the occurrence, risk factors, effect of antifungal
prophylaxis, and outcomes of invasive fungal infections (IFIs) in patients with acute myeloid …

Few reports analyze the incidence and clinical outcome of invasive fungal disease (IFD) in
patients with newly diagnosed acute myeloid leukemia (AML) undergoing intensive …

Background Invasive fungal disease (IFD) is a major complication of acute leukemia, thus
primary antifungal prophylaxis (PAP) is recommended by guidelines. Nevertheless …

Invasive fungal infections (IFIs) remain an important cause of morbidity and mortality in
patients with acute or chronic leukemia. Advances in the pharmacotherapy of fungal …

Invasive fungal infections (IFIs) are a leading cause of morbidity and attributable mortality in
oncohematologic patients. Timely diagnosis is essential but challenging. Herein we …